CAI · Company research
Caris Life Sciences, Inc. Common Stock (CAI): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 27.1 | $8,981,713,367.5 | 8290798367.50 | 52.0869870220975096 | — | — | 34.0587965943908506 | 15.1786332499062079 | 315.40237270428767074326 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.